New Delhi|HL
The pandemic disease novel corona virus’s outbreak is still in its second stage in India said Prof.Balram Bhargava Secretary, Department of Health Research & Director General-Indian Council of Medical Research while addressing the media on Tuesday in New Delhi.
Indian Council of Medical Research (ICMR), the apex health research body of India has activated more laboratories to test for COVID-19 and revised the testing criteria for the same. The Council has equipped 72 of its laboratories to test for the pandemic disease adds Dr.Bhargava.
Dr.Bhargava also highlighted about the new strategies and criteria to be followed for COVID-19 are:
More Laboratories: In addition to these labs 49 more laboratories under organizations like Council of Scientific & Industrial Research (CSIR), Department of Biotechnology (DBT), and Defence Research, Development Organisation (DRDO) would be equipped to test for COVID19 by end of this week. ICMR will also be setting up two testing locations (NCR and Bhubaneswar) for high throughput diagnostic systems for exponentially increasing rapid diagnosing of COVID-19. These systems can test up to 1400 samples in a day.
Revised Testing Criteria: ICMR has also revised the testing criteria for COVID-19 under which an individual should home quarantine themselves for 14 days if they qualify for the following conditions: 1. Direct close physical contact of laboratory-confirmed positive case 2. History of travel in the last 14 days to high-risk COVID-19 affected countries.
If the person develops symptoms like fever, cough and difficulty in breathing they should immediately contact the Ministry of Health and Family Welfare helpline for testing. If the person is asymptomatic, they do not require a laboratory test.
In addition to these conditions, if a healthcare worker managing respiratory distress/Severe Acute Respiratory Illness shows symptoms of acute respiratory illness they should get a laboratory test for COVID-19.
If these cases are tested positive, then they should be isolated and treated as per the standard protocols.
Monitoring: Prof (Dr) Balram Bhargava, also states “We at ICMR are regularly monitoring for community transmissions. Our labs are looking at random samples of patients who suffer from influenza-like illnesses/ Severe Acute Respiratory Illness for presence of the COVID-19.So far, these results are negative thus implying that India has not reached the stage for community transmissions.
